ForumIAS LATEST
- SFG FRC 2027 | Program starts from 18th Dec. 2026 | Admissions open for Entrance Test Click Here to know more →
- Prelims Test Series (PTS) for Prelims 2027 starts 11th Oct. 2026 Click Here to know more →
- [Pre-order] Ethics Redbook 3rd Edition: Delivery starts from 10th October onwards Click Here to Read More →
- 21 Sept. | GS Advance Program (GSAP) for UPSC 2027 Mains starts from 11th Oct. Click Here to Read More →
What is the News?
Drugs Controller General of India(DGCI) has given emergency use authorisation to Corbevax vaccine for use in children between 12 and 18 years of age.
What is Corbevax Vaccine?
Corbevax is India’s first indigenously developed Receptor Binding Domain (RBD) protein subunit vaccine.
Manufactured by: Hyderabad-based Biological E.
Click Here to read more about Corbevax
Is this the first vaccine approved for use in Children?
No, Corbevax is the third vaccine approved by the DCGI for children’s use after Covaxin and Zydus Cadila’s ZyCoV-D.
But currently, only Covaxin is used in the inoculation drive for children in the 15-18 age group.
Source: This post is based on the article “CORBEVAX receives DCGI approval for Emergency Use Authorization (EUA) for 12-18 years age group” published in PIB on 25th February 2022
